The present application relates to new substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones, to methods for the synthesis thereof, the use thereof alone or in combination for the treatment and/or prophylaxis of diseases, and the use thereof for manufacturing medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of inflammatory pulmonary diseases.